ShangPharma In­no­va­tion en­ters into part­ner­ship with UCSF

BioSpectrum (Asia) - - Company News -

In a new col­lab­o­ra­tion, ShangPharma In­no­va­tion, Inc. (SPII) is pro­vid­ing fund­ing and other sup­port to sci­en­tists at UC San Fran­cisco (UCSF) to ac­cel­er­ate the devel­op­ment of promis­ing life science in­ven­tions. The part­ner­ship helps ad­vance a ma­jor new ini­tia­tive at UCSF to bridge aca­demic re­search with in­dus­trial devel­op­ment. Part of this ef­fort, which SPII will sup­port, in­volves back­ing pre­clin­i­cal re­search to val­i­date drug tar­gets and to de­velop pro­grams to dis­cover new drugs. Drugs that UCSF and SPII de­ter­mine to be promis­ing in pre­clin­i­cal stud­ies can then be read­ied for clin­i­cal tri­als to demon­strate safety and ef­fi­cacy in pa­tients. The col­lab­o­ra­tion agree­ment an­tic­i­pates that SPII will pro­vide sev­eral years of fund­ing to carry out R&D in UCSF lab­o­ra­to­ries. SPII also will com­mit to spend ad­di­tional amounts each year dur­ing the term of the col­lab­o­ra­tion to pur­chase Con­tract Re­search Or­ga­ni­za­tion (CRO) ser­vices in sup­port of the projects be­ing con­ducted by SPII and UCSF. CRO ser­vices will be pro­vided by Shang­hai ChemPart­ner Co. Ltd. (ChemPart­ner). SPII and UCSF will share in fu­ture value created through this in­no­va­tive part­ner­ship.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.